Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 117 results found. Search for [ Russian vaccine trials in India ]

Results 1 to 21 of 117
BusinessToday.In
November 25, 2020
Indian drug regulator may provide an emergency approval to AstraZeneca's COVID-19 vaccine by end-December or early January 21, says Nomura


Joe C Mathew
November 24, 2020
The announcement that comes a day after Oxford-Astrazeneca announced a similar level of efficacy for its COVID-19 vaccine allows India to hope for two vaccines to fight the COVID-19 pandemic in the country


BusinessToday.In
November 24, 2020
Vardhan says it makes no sense to consider Pfizer as pharma major is yet to get approval in the US. After requisite approvals, US pharma major will have to cater to needs of its own country's population first


BusinessToday.In
November 23, 2020
The panel-led by Dravida Munnetra Kazhagam (DMK) lawmaker Kanimozhi Karunanidhi will hear officials of pharmaceutical departments on the status of the COVID-19 vaccine


BusinessToday.In
November 23, 2020
The Prime Minister is expected to hold two back-to-back meetings, one with those states with high caseloads and another related to vaccine distribution strategy.


Reuters
November 22, 2020
The twin crises of the pandemic and an uneven, uncertain global recovery dominated the first day of a two-day summit under the chairmanship of Saudi Arabia, which hands off the rotating presidency of the G20 to Italy next month


Joe C Mathew
November 21, 2020
\"We expect emergency authorisation for Oxford-Astrazeneca vaccine to be sought in the UK. If so, it will give an opportunity for India regulator also (to consider such an option),\" says Dr Vinod Paul, chairman of the National Expert Group on Vaccine Administration for COVID-19


BusinessToday.In
November 21, 2020
Bharat Biotech, the developer of India's indigenous vaccine Covaxin, has said that it is planning to enrol about 2,000 participants each in metros for Phase-3 trials of its COVID-19 vaccine that began earlier this week


BusinessToday.In
November 21, 2020
Pfizer that its EUA submission is supported by solicited safety data from a randomised subset of approximately 8,000 participants aged 18 years or above and unsolicited safety data from approximately 38,000 trial participants


Reuters
November 18, 2020
The link will send users directly to authoritative COVID-19 vaccine information from a third-party source like the Centers for Disease Control and Prevention or the World Health Organization (WHO)


BusinessToday.In
November 17, 2020
The approval to conduct Phase 2 and Phase 3 trials was granted to Dr Reddy's laboratory by the Drug Controller General of India (DCGI)


BusinessToday.In
November 17, 2020
Russian news agency TASS says Putin also proposed an increase in the pace of the creation of a vaccine research centre for BRICS countries Brazil, Russia, India, China and South Africa


PTI
November 15, 2020
College principal R B Kamal said the effect of the vaccine on the volunteers will be studied for seven months after the same is administered once, twice or thrice within an interval of 21 day


BusinessToday.In
November 15, 2020
As per Anthony Fauchi, the Pfizer's vaccine distribution process in the US will start in December. This, he said, will also help reduce the daily spike in coronavirus cases, which reached 1.9 lakh this week


Associated Press
November 14, 2020
Microsoft said that most of the attacks in recent months were unsuccessful, but provided no information on how many succeeded or how serious those breaches were


BusinessToday.In
November 13, 2020
On nations hoarding vaccine stocks to meet their requirements first, Dmitriev said it is not about vaccine nationalism and that India is an important partner


BusinessToday.In
November 12, 2020
US-based Moderna Inc has claimed that it has sufficient data for a first interim analysis of the advanced-phase trial of its COVID-19 vaccine candidate, which should help ascertain the inoculation's efficacy


BusinessToday.In
November 11, 2020
Russia coronavirus vaccine: The interim trial results were announced by Russia's sovereign wealth fund Russian Direct Investment Fund on Wednesday. RDIF is backing the vaccine and marketing it globally


BusinessToday.In
November 11, 2020
The major hurdle for the vaccine is storage and distribution. Pfizer's COVID-19 vaccine candidate needs to be stored at temperatures of minus 70 degrees Celsius (-94 F) or below


BusinessToday.In
November 10, 2020
Sputnik V vaccine, developed by the Gamaleya National Research Institute of Epidemiology, was registered by the Russian Health Ministry


PAGES 1 OF 6  12345